Alliancebernstein L.P. Adaptive Biotechnologies Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 128,387 shares of ADPT stock, worth $994,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,387

Previous 138,797 7.5%

Holding current value

$994,999

Previous $502,000 30.88%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.37 - $5.12 $35,081 - $53,299	-10,410 Reduced 7.5%	128,387 $657,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $45,866 - $77,619	19,601 Added 16.44%	138,797 $502,000
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $35,049 - $58,416	-12,170 Reduced 9.26%	119,196 $382,000
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $2,871 - $4,423	-830 Reduced 0.63%	131,366 $643,000
Q3 2022 Nov 15, 2022	SELL	$6.5 - $12.67 $43,062 - $83,938	-6,625 Reduced 4.77%	132,196 $941,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $609,708 - $1.4 Million	95,267 Added 218.73%	138,821 $1.12 Million
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $11,465 - $32,743	-1,133 Reduced 2.54%	43,554 $605,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $96,879 - $141,835	-3,849 Reduced 7.93%	44,687 $1.25 Million
Q3 2021 Nov 10, 2021	SELL	$30.02 - $39.87 $25,877 - $34,367	-862 Reduced 1.75%	48,536 $1.65 Million
Q2 2021 Jul 30, 2021	BUY	$32.22 - $44.59 $204,113 - $282,477	6,335 Added 14.71%	49,398 $2.02 Million
Q1 2021 May 06, 2021	BUY	$37.26 - $67.74 $15,351 - $27,908	412 Added 0.97%	43,063 $1.73 Million
Q4 2020 Feb 08, 2021	BUY	$45.01 - $65.47 $209,296 - $304,435	4,650 Added 12.24%	42,651 $2.52 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $152,107 - $207,442	4,250 Added 12.59%	38,001 $1.85 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $98,053 - $190,133	3,930 Added 13.18%	33,751 $1.63 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $63,260 - $127,416	3,730 Added 14.3%	29,821 $828,000
Q4 2019 Feb 18, 2020	BUY	$24.56 - $32.8 $292,018 - $389,991	11,890 Added 83.73%	26,091 $781,000
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $1.84 Million - $3.25 Million	-60,799 Reduced 81.07%	14,201 $439,000
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $3.02 Million - $3.62 Million	75,000 New	75,000 $3.62 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

144M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.11B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Adaptive Biotechnologies Corp Transaction History